Send to

Choose Destination
See comment in PubMed Commons below
Blood Cells Mol Dis. 2004 Nov-Dec;33(3):271-3.

Cord blood transplantation for children with acute leukaemia: a Eurocord registry analysis.

Author information

Hematology-Bone Marrow Transplant Department and Eurocord Office, Hospital Saint Louis, Paris, France.



Report results of unrelated cord blood transplants collected by Eurocord Registry in children with acute leukemia.


Children with AML: 95 children were analyzed. The two year leukemia free survival was 42% in patients transplanted in first remission, 50% in second remission and 21% in children not in remission. Children with poor prognostic cytogenetic features had the same survival compared to other patients. Children with ALL: 195 patients with ALL were analyzed. The two year leukemia free survival was 36% in patients transplanted in remission and 15% in patients transplanted in relapse. Results of unrelated cord blood transplants compared to unrelated bone marrow transplants in children with acute leukemia: 416 children with acute leukemia received a HLA matched unrelated bone marrow transplant and were compared to 99 children transplanted with an unrelated HLA mismatched cord blood. The long term outcome between these groups were comparable with delayed engraftment in cord blood transplant, more relapse in T cell depleted bone marrow transplant and more GVH in the unmanipulated bone marrow transplant resulting in similar 5 years leukemia free survival.


These results show that use of unrelated cord blood transplant is an option in patients lacking an HLA identical sibling donor.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center